Stay updated with breaking news from Nasdaq Blph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research note published on Tuesday. The brokerage issued a hold rating on the biotechnology company’s stock. Several other equities analysts have also commented on the stock. Laidlaw lowered shares of Bellerophon Therapeutics from a buy rating to a hold rating in […]
Analysts at StockNews.com began coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Free Report) in a report released on Tuesday. The brokerage set a “hold” rating on the biotechnology company’s stock. BLPH has been the topic of several other research reports. HC Wainwright dropped their price objective on shares of Bellerophon Therapeutics from $30.00 […]
StockNews.com assumed coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report released on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock. BLPH has been the topic of a number of other research reports. HC Wainwright reduced their target price on Bellerophon Therapeutics from $30.00 to $2.00 […]
StockNews.com initiated coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report issued on Sunday. The brokerage issued a hold rating on the biotechnology company’s stock. Several other equities research analysts have also recently issued reports on the stock. Brookline Capital Management cut shares of Bellerophon Therapeutics from a buy rating to […]
StockNews.com assumed coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research note published on Friday. The firm issued a hold rating on the biotechnology company’s stock. A number of other equities analysts have also commented on BLPH. Laidlaw lowered Bellerophon Therapeutics from a buy rating to a hold rating in a […]